Search Results - "Weinshenker, B G"

Refine Results
  1. 1

    MOG encephalomyelitis: international recommendations on diagnosis and antibody testing by Jarius, S, Paul, F, Aktas, O, Asgari, N, Dale, R C, de Seze, J, Franciotta, D, Fujihara, K, Jacob, A, Kim, H J, Kleiter, I, Kümpfel, T, Levy, M, Palace, J, Ruprecht, K, Saiz, A, Trebst, C, Weinshenker, B G, Wildemann, B

    Published in Journal of neuroinflammation (03-05-2018)
    “…Over the past few years, new-generation cell-based assays have demonstrated a robust association of autoantibodies to full-length human myelin oligodendrocyte…”
    Get full text
    Journal Article
  2. 2

    NMO-IgG predicts the outcome of recurrent optic neuritis by MATIELLO, M, LENNON, V. A, JACOB, A, PITTOCK, S. J, LUCCHINETTI, C. F, WINGERCHUK, D. M, WEINSHENKER, B. G

    Published in Neurology (03-06-2008)
    “…To determine the prognostic value of neuromyelitis optica (NMO)-immunoglobulin G (IgG) in patients with recurrent optic neuritis (ON). The aquaporin-4-specific…”
    Get full text
    Journal Article
  3. 3

    Revised diagnostic criteria for neuromyelitis optica by WINGERCHUK, D. M, LENNON, V. A, PITTOCK, S. J, LUCCHINETTI, C. F, WEINSHENKER, B. G

    Published in Neurology (23-05-2006)
    “…The authors previously proposed diagnostic criteria for neuromyelitis optica (NMO) that facilitate its distinction from prototypic multiple sclerosis (MS)…”
    Get full text
    Journal Article
  4. 4

    Differential diagnosis of suspected multiple sclerosis: a consensus approach by Miller, DH, Weinshenker, BG, Filippi, M, Banwell, BL, Cohen, JA, Freedman, MS, Galetta, SL, Hutchinson, M, Johnson, RT, Kappos, L, Kira, J, Lublin, FD, McFarland, HF, Montalban, X, Panitch, H, Richert, JR, Reingold, SC, Polman, CH

    Published in Multiple sclerosis (01-11-2008)
    “…Background and objectives Diagnosis of multiple sclerosis (MS) requires exclusion of diseases that could better explain the clinical and paraclinical findings…”
    Get full text
    Journal Article Conference Proceeding
  5. 5

    Azathioprine: Tolerability, efficacy, and predictors of benefit in neuromyelitis optica by COSTANZI, C, MATIELLO, M, LUCCHINETTI, C. F, WEINSHENKER, B. G, PITTOCK, S. J, MANDREKAR, J, THAPA, P, MCKEON, A

    Published in Neurology (16-08-2011)
    “…To evaluate the efficacy, tolerability, optimal dosing, and monitoring of azathioprine in patients with neuromyelitis optica (NMO). This was a chart review and…”
    Get full text
    Journal Article
  6. 6

    Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up by Petzold, Axel, Woodhall, Mark, Khaleeli, Z, Tobin, W Oliver, Pittock, Sean J, Weinshenker, B G, Vincent, Angela, Waters, Patrick, Plant, Gordon T

    “…ObjectivesTo re-evaluate serum samples from our 2007 cohort of patients with single-episode isolated ON (SION), recurrent isolated ON (RION), chronic relapsing…”
    Get full text
    Journal Article
  7. 7

    A population-based prospective study of optic neuritis by Soelberg, K, Jarius, S, Skejoe, HPB, Engberg, H, Mehlsen, JJ, Nilsson, AC, Madsen, JS, Reindl, M, Wildemann, B, Grauslund, J, Kyvik, KO, Smith, TJ, Lillevang, ST, Paul, F, Weinshenker, BG, Asgari, N

    Published in Multiple sclerosis (01-12-2017)
    “…Background: Optic neuritis (ON) is often associated with multiple sclerosis (MS). Early diagnosis is critical to optimal patient management. Objective: To…”
    Get full text
    Journal Article
  8. 8

    Evidence-based guideline: Clinical evaluation and treatment of transverse myelitis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology by SCOTT, T. F, FROHMAN, E. M, DE SEZE, J, GRONSETH, G. S, WEINSHENKER, B. G

    Published in Neurology (13-12-2011)
    “…To assess the evidence for diagnostic tests and therapies for transverse myelitis (TM) and make evidence-based recommendations. A review of the published…”
    Get full text
    Journal Article
  9. 9

    Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders by BANWELL, B, TENEMBAUM, S, LENNON, V. A, URSELL, E, KENNEDY, J, BAR-OR, A, WEINSHENKER, B. G, LUCCHINETTI, C. F, PITTOCK, S. J

    Published in Neurology (29-01-2008)
    “…To determine seroprevalence of neuromyelitis optica (NMO)-IgG in childhood CNS inflammatory demyelinating disorders. We analyzed demographic, clinical, and…”
    Get full text
    Journal Article
  10. 10

    Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders by MAGANA, S. M, MATIELLO, M, PITTOCK, S. J, MCKEON, A, LENNON, V. A, RABINSTEIN, A. A, SHUSTER, E, KANTARCI, O. H, LUCCHINETTI, C. F, WEINSHENKER, B. G

    Published in Neurology (24-02-2009)
    “…Posterior reversible encephalopathy syndrome (PRES) is characterized by vasogenic subcortical edema without infarction. It has been associated with…”
    Get full text
    Journal Article
  11. 11

    Neuromyelitis optica unique area postrema lesions: Nausea, vomiting, and pathogenic implications by POPESCU, B. F. Gh, LENNON, V. A, LUCCHINETTI, C. F, PARISI, J. E, HOWE, C. L, WEIGAND, S. D, CABRERA-GOMEZ, J. A, NEWELL, K, MANDLER, R. N, PITTOCK, S. J, WEINSHENKER, B. G

    Published in Neurology (05-04-2011)
    “…To characterize the neuropathologic features of neuromyelitis optica (NMO) at the medullary floor of the fourth ventricle and area postrema. Aquaporin-4 (AQP4)…”
    Get full text
    Journal Article
  12. 12

    Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis by Petzold, A, Pittock, S, Lennon, V, Maggiore, C, Weinshenker, B G, Plant, G T

    “…The clinical course of immune mediated optic neuritis (ON) will depend on the specific underlying inflammatory disease. These disorders have traditionally been…”
    Get full text
    Journal Article
  13. 13

    Paraneoplastic isolated myelopathy: Clinical course and neuroimaging clues by FLANAGAN, E. P, MCKEON, A, PITTOCK, S. J, LENNON, V. A, KEARNS, J, WEINSHENKER, B. G, KRECKE, K. N, MATIELLO, M, KEEGAN, B. M, MOKRI, B, AKSAMIT, A. J

    Published in Neurology (14-06-2011)
    “…To report the clinical phenotype and outcome of isolated paraneoplastic myelopathy. We systematically reviewed clinical, serologic, and MRI data for 31…”
    Get full text
    Journal Article
  14. 14

    Plasma exchange for severe attacks of CNS demyelination: predictors of response by KEEGAN, M, PINEDA, A. A, MCCLELLAND, R. L, DARBY, C. H, RODRIGUEZ, M, WEINSHENKER, B. G

    Published in Neurology (08-01-2002)
    “…The authors reviewed 59 consecutive patients treated with plasma exchange (PE) for acute, severe attacks of CNS demyelination at Mayo Clinic from January 1984…”
    Get full text
    Journal Article
  15. 15

    CNS aquaporin-4 autoimmunity in children by MCKEON, A, LENNON, V. A, WEINSHENKER, B. G, KRECKE, K, LUCCHINETTI, C. F, PITTOCK, S. J, LOTZE, T, TENENBAUM, S, NESS, J. M, RENSEL, M, KUNTZ, N. L, FRYER, J. P, HOMBURGER, H, HUNTER, J

    Published in Neurology (08-07-2008)
    “…In adult patients, autoantibodies targeting the water channel aquaporin-4 (AQP4) are a biomarker for a spectrum of CNS inflammatory demyelinating disorders…”
    Get full text
    Journal Article
  16. 16

    Familial neuromyelitis optica by MATIELLO, M, KIM, H. J, KIM, W, BRUM, D. G, BARREIRA, A. A, KINGSBURY, D. J, PLANT, G. T, ADONI, T, WEINSHENKER, B. G

    Published in Neurology (27-07-2010)
    “…Detection of aquaporin-4-specific immunoglobulin G (IgG) has expanded the spectrum of neuromyelitis optica (NMO). Rare reports of familial aggregation have…”
    Get full text
    Journal Article
  17. 17

    Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG by Nakashima, I, Fujihara, K, Miyazawa, I, Misu, T, Narikawa, K, Nakamura, M, Watanabe, S, Takahashi, T, Nishiyama, S, Shiga, Y, Sato, S, Weinshenker, B G, Itoyama, Y

    “…This study investigates the relation between the serological status of NMO (neuromyelitis optica)-IgG and the clinical and MRI features in Japanese patients…”
    Get full text
    Journal Article
  18. 18

    Absence of cortical demyelination in neuromyelitis optica by POPESCU, B. F. Gh, PARISI, J. E, CABRERA-GOMEZ, J. A, NEWELL, K, MANDLER, R. N, PITTOCK, S. J, LENNON, V. A, WEINSHENKER, B. G, LUCCHINETTI, C. F

    Published in Neurology (07-12-2010)
    “…To asses the presence of cortical demyelination in brains of patients with neuromyelitis optica (NMO). NMO is an autoimmune inflammatory demyelinating disease…”
    Get full text
    Journal Article
  19. 19

    A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis by WINGERCHUK, D. M, BENARROCH, E. E, O'BRIEN, P. C, KEEGAN, B. M, LUCCHINETTI, C. F, NOSEWORTHY, J. H, WEINSHENKER, B. G, RODRIGUEZ, M

    Published in Neurology (12-04-2005)
    “…Pharmacotherapeutic options for multiple sclerosis (MS)-related fatigue are limited. Thirty patients were randomly assigned to aspirin (ASA) 1,300 mg/day or…”
    Get full text
    Journal Article
  20. 20

    Genetic analysis of aquaporin-4 in neuromyelitis optica by MATIELLO, M, SCHAEFER-KLEIN, J. L, HEBRINK, D. D, KINGSBURY, D. J, ATKINSON, E. J, WEINSHENKER, B. G

    Published in Neurology (20-09-2011)
    “…Autoantibodies to aquaporin-4 (AQP4) are specific and pathogenic for neuromyelitis optica (NMO). Therefore, we evaluated whether AQP4 single-nucleotide…”
    Get full text
    Journal Article